2,5-dimethoxy-4-bromoamphetamine has been researched along with 2,5-dimethoxyamphetamine in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (36.84) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 6 (31.58) | 29.6817 |
2010's | 2 (10.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glennon, RA; Liebowitz, SM; Mack, EC | 1 |
Hall, LH; Kier, LB | 1 |
Bartyzel, P; Glennon, RA; Leonhardt, S; Raghupathi, R; Teitler, M | 1 |
Huang, XM; Johnson, MP; Nichols, DE; Oberlender, R; Snyder, SE | 1 |
Glennon, RA; Lyon, RA; Roth, BL; Seggel, MR; Suba, EA; Titeler, M; Yousif, MY | 1 |
Glennon, RA | 2 |
Glennon, RA; Lyon, RA; McKenney, JD; Titeler, M | 1 |
Benington, F; Glennon, RA; Morin, RD; Young, R | 1 |
Anderson, GM; Castagnoli, N; Domelsmith, LN; Eaton, TA; Glennon, RA; Houk, KN; Kollman, PA; Shulgin, AT | 1 |
Anderson, GM; Glennon, RA; Liebowitz, SM | 1 |
Clare, BW | 1 |
Dowd, CS; DuPre, A; Egan, C; Glennon, RA; Herrick-Davis, K; Smith, C; Teitler, M | 1 |
Glennon, RA; Peddi, S; Roth, BL; Westkaemper, RB | 1 |
Cassels, BK; Castillo, M; Fierro, A; Gallardo-Godoy, A; McLean, TH; Nichols, DE; Reyes-Parada, M | 1 |
Kurrasch, DM; Nichols, DE; Parker, MA | 1 |
Glennon, RA; Mosier, PD; Roth, BL; Runyon, SP; Westkaemper, RB | 1 |
Ewald, AH; Maurer, HH | 1 |
Burrai, L; Nieddu, M; Palomba, M; Pirisi, MA | 1 |
1 review(s) available for 2,5-dimethoxy-4-bromoamphetamine and 2,5-dimethoxyamphetamine
Article | Year |
---|---|
Central serotonin receptors as targets for drug research.
Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin | 1987 |
18 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and 2,5-dimethoxyamphetamine
Article | Year |
---|---|
Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues.
Topics: Amines; Animals; Female; Hallucinogens; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; N,N-Dimethyltryptamine; Rats; Receptors, Serotonin; Stomach; Tryptamines | 1978 |
Structure-activity studies on hallucinogenic amphetamines using molecular connectivity.
Topics: Amphetamines; Chemical Phenomena; Chemistry, Physical; Hallucinogens; Models, Chemical; Structure-Activity Relationship | 1977 |
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
Topics: Animals; Binding Sites; Binding, Competitive; Ergolines; Ketanserin; Male; Molecular Structure; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Structure-Activity Relationship; Tritium | 1992 |
2,3-Dihydrobenzofuran analogues of hallucinogenic phenethylamines.
Topics: Animals; Benzofurans; Cerebral Cortex; Discrimination, Psychological; Hallucinogens; Indicators and Reagents; Learning; Lysergic Acid Diethylamide; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Phenethylamines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Structure-Activity Relationship | 1991 |
A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors.
Topics: Amphetamines; Animals; In Vitro Techniques; Ketanserin; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Solubility; Structure-Activity Relationship | 1990 |
5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.
Topics: Animals; Anisoles; Binding, Competitive; Generalization, Stimulus; In Vitro Techniques; Male; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Stereoisomerism; Structure-Activity Relationship | 1986 |
Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
Topics: Amphetamines; Animals; Behavior, Animal; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; In Vitro Techniques; Isomerism; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1982 |
Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues.
Topics: Amphetamines; Animals; Chemical Phenomena; Chemistry, Physical; Humans; Psychotropic Drugs; Rabbits; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 1981 |
Serotonin receptor affinities of psychoactive phenalkylamine analogues.
Topics: Amines; Animals; Female; Hallucinogens; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Receptors, Serotonin; Stomach; Structure-Activity Relationship | 1980 |
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory | 1998 |
1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
Topics: 3T3 Cells; Animals; Cell Line; Inositol Phosphates; Ligands; Mice; Propylamines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 2000 |
Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor.
Topics: Cyclopentanes; Indicators and Reagents; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Structure-Activity Relationship | 2003 |
Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Topics: Animals; Binding Sites; Brain; Clorgyline; Crystallography, X-Ray; In Vitro Techniques; Male; Methylation; Mitochondria; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley | 2005 |
The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands.
Topics: Anthracenes; Catalysis; Hydrophobic and Hydrophilic Interactions; Ligands; Lipids; Molecular Structure; Phenethylamines; Protein Binding; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Serotonin Receptor Agonists | 2008 |
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
Topics: Animals; Anthracenes; Cattle; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis; Protein Binding; Receptor, Serotonin, 5-HT2A; Sequence Alignment; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2008 |
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
Topics: Algorithms; Amphetamines; Animals; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Designer Drugs; DOM 2,5-Dimethoxy-4-Methylamphetamine; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Hydroxylation; Insecta; Kinetics; Microsomes, Liver; Molecular Structure; Quinidine; Spectrometry, Mass, Electrospray Ionization | 2008 |
Identification and quantitation of 4-bromo-2,5-dimethoxyamphetamine in seized blotters.
Topics: Amphetamines; Chromatography, Liquid; DOM 2,5-Dimethoxy-4-Methylamphetamine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Illicit Drugs; Italy; Reproducibility of Results | 2015 |